Amantadine: Difference between revisions
Jump to navigation
Jump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<applet load="" size="480" color="" frame="true" spin="on" Scene ="Amantadine/Amantadine/1" align="right" caption="Amantadine, also known as Symmetrel"/> | <applet load="" size="480" color="" frame="true" spin="on" Scene ="Amantadine/Amantadine/1" align="right" caption="Amantadine, also known as Symmetrel"/> | ||
===Better Known as: Symmetrel=== | ===Better Known as: Symmetrel=== | ||
* Marketed By: | * Marketed By: Endo Pharmaceuticals | ||
* Major Indication: [[Influenza]] Infection | * Major Indication: [[Influenza]] Infection | ||
* Drug Class: [[M2 Proton Channel]] Inhibitor | * Drug Class: [[M2 Proton Channel]] Inhibitor | ||